ARDX
insider transactionsARDELYX, INC. — buys & sells by directors, officers and 10% owners A shareholder owning more than 10% of the company. Must report trades, but usually a weaker signal than an officer or director. (SEC Form 4).
Net shares · 90d
-211.3K
0 buy · 211.3K sell
Net value · 90d
-$1.3M
$0 in · $1.3M out
Sentiment · 90d
Net selling
0% buying · 100% selling
Open-market trades · 90d
22
0 buy · 211.3K sell
Net buy / sell volume
Not enough data to chart yet.
Tap or hover the chart for daily net volume. Green = net buying, red = net selling.
All transactions
-
Grant·A
Director
$0
39.7K sh
Own New
-
Grant·A
Director
$0
26.5K sh
Own +19%
-
Grant·A
Director
$0
39.7K sh
Own New
-
Grant·A
Director
$0
26.5K sh
Own +17%
-
Grant·A
Director
$0
39.7K sh
Own New
-
Grant·A
Director
$0
26.5K sh
Own +46%
-
Grant·A
Director
$0
39.7K sh
Own New
-
Grant·A
Director
$0
26.5K sh
Own +64%
-
Grant·A
Director
$0
39.7K sh
Own New
-
Grant·A
Director
$0
26.5K sh
Own +6%
-
Grant·A
Director
$0
39.7K sh
Own New
-
Grant·A
Director
$0
26.5K sh
Own +9%
-
Grant·A
Director
$0
12.3K sh
Own +4%
-
Grant·A
Director
$0
39.7K sh
Own New
-
Grant·A
Director
$0
26.5K sh
Own +1%
-
Grant·A
Director
$0
20.3K sh
Own +1%
-
Exercise·M
Michael Raab KEY
President & CEO · 10b5-1
$0
20.8K sh
Own +7%
-
Sell·S
Michael Raab KEY
President & CEO · 10b5-1
$236.3K
41.7K sh · $5.67
Own -2%
-
Exercise·M
Michael Raab KEY
President & CEO · 10b5-1
$20.6K
20.8K sh · $0.99
Own +1%
-
Sell·S
Chief Financial Officer
$9.1K
1.5K sh · $6.27
Own -1%
-
Sell·S
Chief Human Resources Officer
$11.6K
1.8K sh · $6.27
Own -1%
-
Sell·S
Senior Vice President and Chi…
$6.5K
1.0K sh · $6.27
Own -1%
-
Sell·S
Senior Vice President and Chi…
$16.8K
2.7K sh · $6.27
Own -2%
-
Sell·S
Chief Commercial Officer
$15.1K
2.4K sh · $6.27
Own -1%
-
Sell·S
Chief Commercial Officer
$15.2K
2.4K sh · $6.27
Own -1%
-
Sell·S
Chief Commercial Officer
$19.8K
3.2K sh · $6.27
Own -1%
-
Sell·S
Chief Business Officer
$15.5K
2.5K sh · $6.27
Own -1%
-
Sell·S
Chief Business Officer
$11.7K
1.9K sh · $6.27
Own -1%
-
Sell·S
Chief Business Officer
$18.2K
2.9K sh · $6.27
Own -1%
-
Sell·S
Chief Patient Officer
$8.9K
1.4K sh · $6.27
Own -0%
-
Sell·S
Chief Patient Officer
$12.0K
1.9K sh · $6.27
Own -0%
-
Sell·S
Chief Patient Officer
$13.5K
2.2K sh · $6.27
Own -0%
-
Sell·S
Chief Patient Officer
$9.4K
1.5K sh · $6.27
Own -0%
-
Sell·S
Michael Raab KEY
President & CEO
$87.9K
14.0K sh · $6.27
Own -1%
-
Sell·S
Michael Raab KEY
President & CEO
$112.4K
17.9K sh · $6.27
Own -1%
-
Sell·S
Michael Raab KEY
President & CEO
$49.3K
7.9K sh · $6.27
Own -0%
-
Sell·S
Michael Raab KEY
President & CEO
$93.6K
14.9K sh · $6.27
Own -1%
-
Sell·S
Chief Technical and Quality O…
$14.5K
2.3K sh · $6.27
Own -1%
-
Exercise·M
Michael Raab KEY
President & CEO · 10b5-1
$0
20.8K sh
Own +7%
-
Sell·S
Michael Raab KEY
President & CEO · 10b5-1
$261.6K
41.7K sh · $6.28
Own -2%
-
Exercise·M
Michael Raab KEY
President & CEO · 10b5-1
$20.6K
20.8K sh · $0.99
Own +1%
-
Exercise·M
Michael Raab KEY
President & CEO · 10b5-1
$0
20.8K sh
Own +6%
-
Sell·S
Michael Raab KEY
President & CEO · 10b5-1
$262.0K
41.7K sh · $6.29
Own -2%
-
Exercise·M
Michael Raab KEY
President & CEO · 10b5-1
$20.6K
20.8K sh · $0.99
Own +1%
| Date▾ | Insider | Type | Shares | Value |
|---|---|---|---|---|
| Jun 16, 2026 | Muna Bhanji | Grant A | 39.7K | $0 |
| Jun 16, 2026 | Muna Bhanji | Grant A | 26.5K | $0 |
| Jun 16, 2026 | Onaiza Cadoret-Manier | Grant A | 39.7K | $0 |
| Jun 16, 2026 | Onaiza Cadoret-Manier | Grant A | 26.5K | $0 |
| Jun 16, 2026 | Merdad Parsey | Grant A | 39.7K | $0 |
| Jun 16, 2026 | Merdad Parsey | Grant A | 26.5K | $0 |
| Jun 16, 2026 | Robert B Bazemore | Grant A | 39.7K | $0 |
| Jun 16, 2026 | Robert B Bazemore | Grant A | 26.5K | $0 |
| Jun 16, 2026 | Richard J Rodgers | Grant A | 39.7K | $0 |
| Jun 16, 2026 | Richard J Rodgers | Grant A | 26.5K | $0 |
| Jun 16, 2026 | William C Bertrand JR | Grant A | 39.7K | $0 |
| Jun 16, 2026 | William C Bertrand JR | Grant A | 26.5K | $0 |
| Jun 16, 2026 | William C Bertrand JR | Grant A | 12.3K | $0 |
| Jun 16, 2026 | David M Mott | Grant A | 39.7K | $0 |
| Jun 16, 2026 | David M Mott | Grant A | 26.5K | $0 |
| Jun 16, 2026 | David M Mott | Grant A | 20.3K | $0 |
| Jun 15, 2026 | Michael Raab KEY 10b5-1 | Exercise M | 20.8K | $0 |
| Jun 15, 2026 | Michael Raab KEY 10b5-1 | Sell S | 41.7K | $236.3K |
| Jun 15, 2026 | Michael Raab KEY 10b5-1 | Exercise M | 20.8K | $20.6K |
| May 21, 2026 | Susan Hohenleitner KEY | Sell S | 1.5K | $9.1K |
| May 21, 2026 | James Parker Brady | Sell S | 1.8K | $11.6K |
| May 21, 2026 | Joseph James Reilly KEY | Sell S | 1.0K | $6.5K |
| May 21, 2026 | Joseph James Reilly KEY | Sell S | 2.7K | $16.8K |
| May 21, 2026 | Eric Duane Foster | Sell S | 2.4K | $15.1K |
| May 21, 2026 | Eric Duane Foster | Sell S | 2.4K | $15.2K |
| May 21, 2026 | Eric Duane Foster | Sell S | 3.2K | $19.8K |
| May 21, 2026 | Mike Kelliher | Sell S | 2.5K | $15.5K |
| May 21, 2026 | Mike Kelliher | Sell S | 1.9K | $11.7K |
| May 21, 2026 | Mike Kelliher | Sell S | 2.9K | $18.2K |
| May 21, 2026 | Laura A Williams | Sell S | 1.4K | $8.9K |
| May 21, 2026 | Laura A Williams | Sell S | 1.9K | $12.0K |
| May 21, 2026 | Laura A Williams | Sell S | 2.2K | $13.5K |
| May 21, 2026 | Laura A Williams | Sell S | 1.5K | $9.4K |
| May 21, 2026 | Michael Raab KEY | Sell S | 14.0K | $87.9K |
| May 21, 2026 | Michael Raab KEY | Sell S | 17.9K | $112.4K |
| May 21, 2026 | Michael Raab KEY | Sell S | 7.9K | $49.3K |
| May 21, 2026 | Michael Raab KEY | Sell S | 14.9K | $93.6K |
| May 21, 2026 | John E Bishop | Sell S | 2.3K | $14.5K |
| May 15, 2026 | Michael Raab KEY 10b5-1 | Exercise M | 20.8K | $0 |
| May 15, 2026 | Michael Raab KEY 10b5-1 | Sell S | 41.7K | $261.6K |
| May 15, 2026 | Michael Raab KEY 10b5-1 | Exercise M | 20.8K | $20.6K |
| Apr 15, 2026 | Michael Raab KEY 10b5-1 | Exercise M | 20.8K | $0 |
| Apr 15, 2026 | Michael Raab KEY 10b5-1 | Sell S | 41.7K | $262.0K |
| Apr 15, 2026 | Michael Raab KEY 10b5-1 | Exercise M | 20.8K | $20.6K |
About ARDX insider trading
This page tracks insider transactions for ARDELYX, INC. (ARDX) reported to the U.S. Securities and Exchange Commission on Form 4. Corporate insiders — directors, executive officers and beneficial owners of more than 10% of the stock — must disclose their trades within two business days. Open-market purchases (code P) and sales (code S) made at the insider's discretion are the most-watched opportunistic signals, while awards (A), option exercises (M) and tax-withholding (F) reflect compensation rather than conviction. Trades marked 10b5-1 were made under a pre-arranged plan and are considered routine. A cluster buy — several insiders buying within a short window — is historically a stronger bullish indicator than any single trade.